Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 465, Issue 1-2, 2000, Pages 131-137

  Antunes, Lusânia M Greggi ^a   Araújo, Maria Cristina P ^b   Darin, Joana D'Arc C ^a   Bianchi, Maria De Lourdes P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Anticlastogenesis; Chromosomal damage; Cisplatin; Curcumin; Rat

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CISPLATIN; CURCUMIN;

ANIMAL CELL; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW CELL; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CISPLATIN; DRUG INTERACTIONS; FREE RADICAL SCAVENGERS; MALE; MUTAGENS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0342879897     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00220-X     Document Type: Article

References (37)

1. E. Kunchandy, M.N.A. Rao, Oxygen radical scavenging activity of curcumin, Int. J. Pharm. 58 (1990) 237-240.
2. K. Singletary, C. MacDonald, M. Iovinelli, C. Fisher, M. Wallig, Effect of the β-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene, Carcinogenesis 19 (1998) 1039-1043.
3. T. Kawamori, R. Lubet, V.E. Steele, G.J. Kelloff, R.B. Kaskey, C.V. Rao, B.S. Reddy, Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer, Cancer Res. 59 (1999) 597-601.
4. I. Norris, P. Sriganth, B. Premalatha, Dietary curcumin with cisplatin administration modulates tumor marker indices in experimental fibrosarcoma, Pharmacol. Res. 39 (1999) 175-179.
5. S.K. Abraham, L. Sarma, P.C. Kesavan, Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage, Mutat. Res. 303 (1993) 109-112.
6. K.C. Thresiamma, J. George, R. Kuttan, Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity, Indian J. Exp. Biol. 34 (1996) 845-847.
7. K.C. Thresiamma, J. George, R. Kuttan, Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity, J. Exp. Clin. Cancer Res. 17 (1998) 431-434.
8. M. Nagabhushan, A.J. Amonkar, S.V. Bhide, In vitro antimutagenicity of curcumin against environmental mutagens, Food Chem. Toxicol. 25 (1987) 545-547.
9. L.M.G. Antunes, M.C.P. Araújo, F.L. Dias, C.S. Takahashi, Modulatory effects of curcumin on the chromosomal damage induced in Chinese hamster ovary cells, Teratog., Carcinog., Mutagen. 19 (1999) 1-8.
10. M.C.P. Araújo, F.L. Dias, S.N. Kronka, C.S. Takahashi, Effects of turmeric and its active principle, curcumin, on bleomycin-induced chromosome aberrations in Chinese hamster ovary cells, Genet. Mol. Biol. 22 (1999) 407-413.
11. D. Anderson, Antioxidant defenses against reactive oxygen species causing genetic and other damage, Mutat. Res. 350 (1996) 103-108.
12. S. Ghaskadbi, S. Rajmachikar, C. Agate, A.H. Kapadi, V.G. Vaidya, Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assay, Teratog., Carcinog., Mutagen. 12 (1992) 11-17.
13. L. Sarma, P.C. Kesavan, Protective effects of vitamins C and E against γ-ray-induced chromosomal damage in mouse, Int. J. Radiat. Biol. 63 (1993) 759-764.
14. L.M.G. Antunes, C.S. Takahashi, Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells, Mutat. Res. 419 (1998) 137-143.
15. J.M. Gentile, S. Rahimi, J. Zwiesler, G.J. Gentile, L.R. Ferguson, Effect of selected antimutagens on the genotoxicity of antitumor agents, Mutat. Res. 402 (1998) 289-298.
16. M. Konopacka, M. Widel, J. Rzeszowska-Wolny, Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells, Mutat. Res. 417 (1998) 85-94.
17. A. Giri, D. Khynriam, S.B. Prasad, Vitamin C mediated protection on cisplatin-induced mutagenicity in mice, Mutat. Res. 421 (1998) 139-148.
18. L.M.G. Antunes, J.D.C. Darin, M.L.P. Blanchi, Anticlastogenic effect of vitamin C on cisplatin in vivo, Genet. Mol. Biol. 22 (1999) 415-418.
19. B. Rosenberg, Fundamental studies with cisplatin, Cancer 55 (1985) 2303-2315.
20. H. Masuda, T. Tanaka, U. Takahama, Cisplatin generates superoxide anion by interaction with DNA in a cell-free system, Biochem. Biophys. Res. Commun. 203 (1994) 1175-1180.
21. U. Kliesh, I.-D. Adler, Micronucleus test in bone marrow of mice treated with 1-nitropropane, 2-nitropropane and cis-platin, Mutat. Res. 192 (1987) 181-184.
22. I.-D. Adler, A. El-Tarras, Clastogenic effects of cis-diamminedichloroplatinum: I. Induction of chromosomal aberrations in somatic and germinal cells of mice, Mutat. Res. 211 (1989) 131-137.
23. T. Ohe, S. Tsuda, Y. Sakata, M. Taniwaki, S. Misawa, T. Abe, cis-Diamminedichloroplatinum(II)-induced sister-chromatid exchanges and chromosome aberration formation in cultured human lymphocytes and their inhibition by sodium thiosulfate, Mutat. Res. 244 (1990) 279-285.
24. S. Osanto, J.C.P. Thijssen, V.M. Woldering, J.L.S. van Rijn, A.T. Natarajan, A.D. Tates, Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma, Environ. Mol. Mutagen. 17 (1991) 71-78.
25. S. Hercberg, P. Galan, P. Preziosi, A.M. Roussel, J. Arnaud, M.J. Richard, D. Malvy, A. Paul-Dauphin, S. Briancon, A. Favier, Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancer, Int. J. Vitam. Nutr. Res. 68 (1998) 3-20.
26. N.I. Weijl, F.J. Cleton, S. Osanto, Free radicals and antioxidants in chemotherapy-induced toxicity, Cancer Treat. Rev. 23 (1997) 209-240.
27. M.J. Mukhopadhyay, A. Saha, A. Mukherjee, Studies on the clastogenic effect of turmeric and curcumin on cyclophosphamide and mitomycin in vivo, Food Chem. Toxicol. 36 (1998) 73-76.
28. C.E. Ford, J.L. Hamerton, A colchicine, hypotonie citrate, squash sequence for mammalian chromosomes, Stain Technol. 3 (1956) 247-251.
29. J.R.K. Savage, Classification and relationships of induced chromosomal structural changes, J. Med. Genet. 13 (1976) 103-122.
30. G.S. Baldew, J.G. McVie, M.A. Van der Valk, G. Los, J.J. De Goeij, N.P.E. Vermeulen, Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen, Cancer Res. 50 (1990) 7031-7036.
31. H.G. Keizer, H.M. Pinedo, G.J. Schuurhuis, H. Joenje, Doxorubicin (adriamycin): a critical review of free radical-dependent mechanism of cytotoxicity, Pharmacol. Ther. 47 (1990) 219-231.
32. N. Sreejayan, M.N.A. Rao, Curcuminoids as potent inhibitors of lipid peroxidation, J. Pharm. Pharmacol. 46 (1994) 1013-1016.
33. A.P. Odin, Vitamins as antimutagens: advantages and some possible mechanisms of antimutagenic action, Mutat. Res. 386 (1997) 39-67.
34. M.I. Edelweiss, A. Trachtenberg, E.X. Pinheiro, J. da-Silva, M. Riegel, H.M. Lizardo-Daudt, M.S. Mattevi, Clastogenic effect of cisplatin on Wistar rat bone marrow cells, Braz. J. Med. Biol. Res. 28 (1995) 679-683.
35. F. Rosselli, L. Zaccaro, M. Venturi, A.M. Rossi, Persistence of drug-induced chromosome aberrations in peripheral blood lymphocytes of the rat, Mutat. Res. 232 (1990) 107-114.
36. A. Arora, M.G. Nair, G.M. Strasburg, Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system, Free Radical Biol. Med. 24 (1998) 1355-1363.
37. D.C. Tavares, A.O. Cecchi, L.M.G. Antunes, C.S. Takahashi, Protective effects of the amino acid glutamine and of ascorbic acid against chromosomal damage induced by doxorubicin in mammalian cells, Teratog., Carcinog., Mutagen. 18 (1998) 153-161.